- Home
- INM vs FE Comparison
INM vs FE Comparison
Compare INM & FE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INM
- FE
- Stock Information
- Founded
- INM 1981
- FE 1996
- Country
- INM Canada
- FE United States
- Employees
- INM N/A
- FE N/A
- Industry
- INM Biotechnology: Pharmaceutical Preparations
- FE Electric Utilities: Central
- Sector
- INM Health Care
- FE Utilities
- Exchange
- INM Nasdaq
- FE Nasdaq
- Market Cap
- INM 3.2M
- FE N/A
- IPO Year
- INM N/A
- FE N/A
- Fundamental
- Price
- INM $2.28
- FE $41.72
- Analyst Decision
- INM
- FE Buy
- Analyst Count
- INM 0
- FE 15
- Target Price
- INM N/A
- FE $46.00
- AVG Volume (30 Days)
- INM 37.3K
- FE 4.7M
- Earning Date
- INM 05-20-2025
- FE 04-23-2025
- Dividend Yield
- INM N/A
- FE 4.27%
- EPS Growth
- INM N/A
- FE 1.45
- EPS
- INM N/A
- FE 1.88
- Revenue
- INM $4,832,013.00
- FE $13,764,000,000.00
- Revenue This Year
- INM N/A
- FE $9.28
- Revenue Next Year
- INM N/A
- FE $3.68
- P/E Ratio
- INM N/A
- FE $22.19
- Revenue Growth
- INM N/A
- FE 8.03
- 52 Week Low
- INM $1.72
- FE $37.58
- 52 Week High
- INM $15.70
- FE $44.97
- Technical
- Relative Strength Index (RSI)
- INM 34.45
- FE 48.57
- Support Level
- INM $2.25
- FE $42.60
- Resistance Level
- INM $3.20
- FE $43.47
- Average True Range (ATR)
- INM 0.21
- FE 0.70
- MACD
- INM -0.08
- FE -0.15
- Stochastic Oscillator
- INM 17.86
- FE 8.14
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.